je.st
news
Tag: receives
PPG Receives Top CAMX 2014 Awards for Technical Papers
2014-10-29 06:00:00| Coatings World Breaking News
Tags: top
technical
awards
papers
BASF receives Materialica Design + Technology Award 2014
2014-10-29 06:00:00| Coatings World Breaking News
Tags: design
technology
award
receives
Vossloh receives approval for DE 12 and DE 18 locomotives in Germany
2014-10-29 01:00:00| Railway Technology
Transport technology manufacturer Vossloh has received approval for its four-axle diesel-electric DE 12 and DE 18 locomotives from Germany's federal railway authority Eisenbahn-Bundesamt (EBA) to operate in the country.
Tags: in
germany
approval
receives
Patrick Cudahy $12.1M expansion receives approval
2014-10-28 17:17:52| Food - Topix.net
Patrick Cudahy LLC, which makes deli meat and bacon, has earned approval to start building a $12.1 million expansion to a meat processing facility in Cudahy. Patrick Cudahy LLC , the Cudahy-based manufacturer of deli meats and bacon, has received approval to start building a $12.1 million, 16,500-square-foot addition to a meat processing plant it built in 2011.
Tags: approval
patrick
expansion
receives
Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA (pembrolizumab) in Advanced Non-Small Cell Lung Cancer
2014-10-27 11:45:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the treatment of patients with Epidermal Growth Factor Receptor (EGFR) mutation-negative, and Anaplastic Lymphoma Kinase (ALK) rearrangement-negative non-small cell lung cancer (NSCLC) whose disease has progressed on or following platinum-based chemotherapy. Language: English Contact: Media Contacts:Pamela Eisele, 267-305-3558orClaire Mulhearn, 908-236-1118orInvestor Contacts:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
cell
cancer
therapy
Sites : [503] [504] [505] [506] [507] [508] [509] [510] [511] [512] [513] [514] [515] [516] [517] [518] [519] [520] [521] [522] next »